The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.815 · Cited by 792
Torsades de Pointes Occurring in Association With Terfenadine Use
Monahan, B. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210088038 · Cited by 667
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
Williams, J. A., Ring, B. J., Cantrell, V. E., Jones, D. R., Eckstein, J., Ruterbories, K., Hamman, M. A., Hall, S. D., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.883 · Cited by 471
Self-citationDrug glucuronidation in humans
Miners, J. O., & Mackenzie, P. I. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90065-t · Cited by 361
Court, M. H., Duan, S. X., von Moltke, L. L., Greenblatt, D. J., Patten, C. J., Miners, J. O., & Mackenzie, P. I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29222-3 · Cited by 301
Transport of organic anions across the basolateral membrane of proximal tubule cells
Burckhardt, B. C., & Burckhardt, G. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-002-0003-8 · Cited by 294
Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
Prueksaritanont, T., Zhao, J. J., Ma, B., Roadcap, B. A., Tang, C., Qiu, Y., Liu, L., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1042 · Cited by 287
Green, M. D., King, C. D., Mojarrabi, B., Mackenzie, P. I., & Tephly, T. R. (1998) · PubMed · Cited by 253
Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Jin, C., Miners, J. O., Lillywhite, K. J., & Mackenzie, P. I. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10294-2 · Cited by 226
Ring, B. J., Catlow, J., Lindsay, T. J., Gillespie, T., Roskos, L. K., Cerimele, B. J., Swanson, S. P., Hamman, M. A., & Wrighton, S. A. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12326-4 · Cited by 214
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance
Miners, J. O., McKinnon, R. A., & Mackenzie, P. I. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00449-3 · Cited by 210
Kinetics of drug-drug interactions
Rowland, M., & Matin, S. B. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059791 · Cited by 208
Stone, A. N., Mackenzie, P. I., Galetin, A., Houston, J. B., & Miners, J. O. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1086 · Cited by 206
Kemp, D. C., Fan, P. W., & Stevens, J. C. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.694 · Cited by 193
SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
Sridar, C., Goosen, T. C., Kent, U. M., Williams, J. A., & Hollenberg, P. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.587 · Cited by 192
Self-citationBenet, L., Cummins, C., & Wu, C. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489389 · Cited by 188
Drug Glucuronidation in Clinical Psychopharmacology
Liston, H. L., Markowitz, J. S., & DeVane, C. L. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00008 · Cited by 177
Court, M. H., Duan, S. X., Guillemette, C., Journault, K., Krishnaswamy, S., von Moltke, L. L., & Greenblatt, D. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1257 · Cited by 174
Kumar, S., Samuel, K., Subramanian, R., Braun, M. P., Stearns, R. A., Chiu, S.-H. L., Evans, D. C., & Baillie, T. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038992 · Cited by 166
Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.
Cheng, Z., Radominska-p, A., & Tephly, T. R. (1999) · PubMed · Cited by 154
Sauer, J., Ponsler, G. D., Mattiuz, E. L., Long, A. J., Witcher, J. W., Thomasson, H. R., & DESANTE, K. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.98 · Cited by 152
THE EFFECT OF INCUBATION CONDITIONS ON THE ENZYME KINETICS OF UDP-GLUCURONOSYLTRANSFERASES
Soars, M. G., Ring, B. J., & Wrighton, S. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.762 · Cited by 152
In vitro and pharmacophore insights into CYP3A enzymes
Ekins, S., Stresser, D. M., & Williams, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00049-x · Cited by 151
Self-citationPharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy
Ramsay, R. E., Pellock, J. M., Garnett, W. R., Sanchez, R. M., Valakas, A. M., Wargin, W. A., Lai, A. A., Hubbell, J. P., Chern, W. H., Allsup, T. L., et al. (1991) · Epilepsy Research · doi:10.1016/0920-1211(91)90012-5 · Cited by 135
Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide
Niemi, M., Backman, J. T., Neuvonen, M., Neuvonen, P. J., & Kivistö, K. T. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115822 · Cited by 130
Barbier, O., Villeneuve, L., Bocher, V., Fontaine, C., Pineda‐Torra, I., Duhem, C., Kosykh, V., Fruchart, J., Guillemette, C., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300749200 · Cited by 129
Ekins, S., Bravi, G., Wikel, J. H., & Wrighton, S. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35117-1 · Cited by 123
Boase, S., & Miners, J. O. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01669.x · Cited by 120
Trapnell, C. B., Klecker, R. W., Jamis‐Dow, C., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1592 · Cited by 108
Bergemann, N., Frick, A., Parzer, P., & Kopitz, J. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-815527 · Cited by 93
Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10
Cheng, Z., Radominska-p, A., & Tephly, T. R. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15041-6 · Cited by 93
Tsoutsikos, P., Miners, J. O., Stapleton, A. M. F., Thomas, A., Sallustio, B. C., & Knights, K. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.025 · Cited by 86
Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
Ling, K. H., Leeson, G. A., Burmaster, S., et al. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06633-4 · Cited by 85
Glucuronidation of Drugs by Hepatic Microsomes Derived from Healthy and Cirrhotic Human Livers
Furlan, V., Demirdjian, S., Bourdon, O., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38249-7 · Cited by 69
Cummings, J., Zelcer, N., Allen, J. D., Yao, D., Boyd, G. W., Malliepaard, M., Friedberg, T., Smyth, J. F., & Jodrell, D. I. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.019 · Cited by 66
Reaction Phenotyping in Drug Discovery: Moving Forward with Confidence?
Williams, J., Hurst, S. I., Bauman, J. N., Jones, B., Hyland, R., Gibbs, J. P., Obach, R. S., & Ball, S. E. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489235 · Cited by 65
Self-citationDutta, S., Zhang, Y., Selness, D. S., Lee, L. L., Williams, L. A., & Sommerville, K. W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00007-4 · Cited by 63
INVOLVEMENT OF HUMAN HEPATIC UGT1A1, UGT2B4, AND UGT2B7 IN THE GLUCURONIDATION OF CARVEDILOL
Ohno, A., Saito, Y., Hanioka, N., Jinno, H., Saeki, M., Ando, M., Ozawa, S., & Sawada, J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.235 · Cited by 62
Boxenbaum, H. G. (1999) · PubMed · Cited by 56
Effect of Valproate on the Pharmacokinetics and Pharmacodynamics of Lorazepam
Samara, E. E., Granneman, R. G., Witt, G. F., et al. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04322.x · Cited by 55
Cheng, Y., & Prusoff, W. H. (1973) · Biochemistry · doi:10.1021/bi00738a010 · Cited by 54
5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA): a New Biological Response Modifier for Cancer Therapy
Zhou, S., Kestell, P., Baguley, B. C., & Paxton, J. W. (2002) · Investigational New Drugs · doi:10.1023/a:1016215015530 · Cited by 50
Inhibition and Active Sites of UDP-Glucuronosyltransferases 2B7 and 1A1.
Rios, G. R., & Tephly, T. R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1364 · Cited by 48
Clinical Pharmacology of Flavopiridol following a 72-Hour Continuous Infusion
Rudek, M. A., Bauer, K. S., Lush, R. M., et al. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c404 · Cited by 42
In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteins
Sallustio, B. C., Knights, K., Roberts, B. J., et al. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90454-d · Cited by 41
Coffman, B. L., Kearney, W. R., Green, M. D., Lowery, R. G., & Tephly, T. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1464 · Cited by 32
Hussein, Z., Mukherjee, D., Lamm, J. E., Cavanaugh, J. H., & Granneman, G. R. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb02036.x · Cited by 32
Cited by
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Rowland, A., Miners, J. O., & Mackenzie, P. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.019 · Cited by 709
Cobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Cytochrome P450s and other enzymes in drug metabolism and toxicity
Guengerich, F. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080112 · Cited by 624
Metadata
- Authors
- Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 32
- Issue
- 11
- Pages
- 1201-1208
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2115763439
- Cited by
- 928
- References
- 48
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.